# TCGA-BRCA Baseline Analysis Prep V1 Findings

This note records human-reviewed findings from the TCGA-BRCA baseline-analysis-prep v1 workflow.

Important reminders:

- this document reviews a baseline-analysis-prep layer only
- this document does not create a final modeling dataset
- this document does not freeze the final endpoint
- this document does not add treatment detail back into the patient-level table
- this document does not replace source files, parsed TSVs, prior audit TSVs, cohort v1 outputs, baseline-analysis-prep outputs, or run logs
- this document covers only the saved pointer-driven baseline-analysis-prep build produced from the current audited TCGA-only evidence
- this document does not include new raw parsing, XML parsing, SSF parsing, METABRIC work, endpoint freeze, treatment modeling, or outcome modeling

## Reviewed Baseline-Analysis-Prep Run ID

- Baseline-analysis-prep latest pointer: `01-data/audit/tcga-brca/analysis-prep/tcga_brca_baseline_analysis_v1_latest.json`
- Reviewed baseline-analysis-prep run id: `[fill in baseline-analysis-prep run id]`
- Source minimal cohort v1 build id: `[fill in cohort v1 build id]`
- Source cohort blueprint run id: `[fill in blueprint run id]`
- Source ambiguity-resolution run id: `[fill in ambiguity-resolution run id]`
- Source clinical shortlist run id: `[fill in shortlist run id]`
- Source endpoint crosswalk run id: `[fill in endpoint crosswalk run id]`
- Review date: `[fill in review date]`
- Reviewed by: `[fill in name or initials]`

## Baseline-Analysis-Prep Inputs Used

- Minimal cohort v1 latest pointer: `01-data/audit/tcga-brca/cohort/tcga_brca_minimal_cohort_v1_latest.json`
- Cohort blueprint latest pointer: `01-data/audit/tcga-brca/cohort/tcga_brca_cohort_blueprint_latest.json`
- Ambiguity-resolution latest pointer: `01-data/audit/tcga-brca/cohort/tcga_brca_blueprint_ambiguity_resolution_latest.json`
- Clinical shortlist latest pointer: `01-data/audit/tcga-brca/variables/tcga_brca_clinical_shortlist_latest.json`
- Endpoint crosswalk latest pointer: `01-data/audit/tcga-brca/variables/tcga_brca_endpoint_crosswalk_latest.json`
- Processed baseline TSV: `01-data/processed/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1.tsv`
- Audit spec TSV: `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1_spec.tsv`
- Audit missingness TSV: `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1_missingness.tsv`
- Audit summary TSV: `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1_summary.tsv`
- Audit run log: `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/run_log.json`
- Review result tables in `09-trials/01-tcga-only-source-audited/05-results/`:
  - `73_baseline_analysis_v1_preview.tsv`
  - `74_baseline_analysis_v1_spec.tsv`
  - `75_baseline_analysis_v1_missingness.tsv`
  - `76_baseline_analysis_v1_followup_coverage.tsv`
  - `77_baseline_analysis_v1_biospecimen_coverage.tsv`
  - `78_baseline_analysis_v1_ambiguity_flags.tsv`
  - `79_baseline_analysis_v1_summary.tsv`

## Final Row Count

Fill from:

- `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1_summary.tsv`
- `09-trials/01-tcga-only-source-audited/05-results/79_baseline_analysis_v1_summary.tsv`

Record only saved baseline-analysis-prep statements.

- `[fill in final row count]`
- `[fill in patient/case unit statement]`
- `[fill in minimal cohort v1 carry-forward statement]`

## Retained Field Categories

Fill from:

- `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1_spec.tsv`
- `09-trials/01-tcga-only-source-audited/05-results/74_baseline_analysis_v1_spec.tsv`

Record the retained categories and field families exactly as saved.

- `[fill in audit/id field summary]`
- `[fill in baseline clinical field summary]`
- `[fill in endpoint candidate field summary]`
- `[fill in biospecimen sample-anchor evidence summary]`
- `[fill in derived prep-flag summary]`

## Missingness Observations

Fill from:

- `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1_missingness.tsv`
- `09-trials/01-tcga-only-source-audited/05-results/75_baseline_analysis_v1_missingness.tsv`

Record only saved missingness observations. Do not impute or reinterpret values in this note.

- `[fill in highest-missingness retained field note]`
- `[fill in follow-up candidate missingness note]`
- `[fill in baseline field completeness note]`

## Follow-Up Coverage

Fill from:

- `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1_summary.tsv`
- `09-trials/01-tcga-only-source-audited/05-results/76_baseline_analysis_v1_followup_coverage.tsv`
- `09-trials/01-tcga-only-source-audited/05-results/79_baseline_analysis_v1_summary.tsv`

Be explicit that follow-up evidence remains provisional and source-specific.

- `[fill in rows with follow-up match]`
- `[fill in rows without follow-up match]`
- `[fill in multirow follow-up note]`

## Biospecimen Sample Coverage

Fill from:

- `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1_summary.tsv`
- `09-trials/01-tcga-only-source-audited/05-results/77_baseline_analysis_v1_biospecimen_coverage.tsv`
- `09-trials/01-tcga-only-source-audited/05-results/79_baseline_analysis_v1_summary.tsv`

Record only the saved sample-anchor evidence behavior. Do not extend this section into child-layer expansion.

- `[fill in biospecimen sample-anchor coverage statement]`
- `[fill in grouped sample barcode evidence statement]`
- `[fill in multirow biospecimen note]`

## Ambiguities Still Carried Forward

Fill from:

- `01-data/processed/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1.tsv`
- `01-data/audit/tcga-brca/analysis-prep/baseline_v1_runs/<BASELINE_ANALYSIS_V1_RUN_ID>/baseline_analysis_v1_summary.tsv`
- `09-trials/01-tcga-only-source-audited/05-results/78_baseline_analysis_v1_ambiguity_flags.tsv`
- `09-trials/01-tcga-only-source-audited/05-results/79_baseline_analysis_v1_summary.tsv`

Be explicit that this prep layer carries unresolved signals forward instead of resolving them.

- `[fill in retained parallel patient-id note]`
- `[fill in endpoint-candidate side-by-side note]`
- `[fill in other carried ambiguity note]`

## What This Table Is Ready For

Summarize only what this baseline-analysis-prep layer honestly supports now.

- `[fill in descriptive statistics readiness]`
- `[fill in missingness review readiness]`
- `[fill in baseline modeling preparation readiness note]`

## What Still Blocks Final Endpoint Freeze or Treatment Modeling

Summarize only what remains unresolved after this baseline-analysis-prep layer. This section must stay at review level only.

- `[fill in endpoint-freeze blocker]`
- `[fill in treatment-modeling blocker]`
- `[fill in any remaining identifier or ambiguity blocker]`

## Validation Checks Completed

- [ ] Baseline-analysis-prep latest pointer resolves to the reviewed run.
- [ ] Reviewed run references the intended cohort v1, blueprint, ambiguity-resolution, shortlist, and endpoint crosswalk runs.
- [ ] Baseline TSV, spec TSV, missingness TSV, summary TSV, and run log all exist and are non-empty.
- [ ] `run_log.json` reports `validation.passed == true`.
- [ ] `run_log.json` reports `no_prior_run_overwrite == true`.
- [ ] `run_log.json` reports `latest_pointer_written_after_success_only == true`.
- [ ] Final baseline-analysis-prep row count is greater than zero.
- [ ] Final baseline-analysis-prep row count equals the source minimal cohort v1 row count.
- [ ] `baseline_analysis_v1_row_id` is sequential.
- [ ] Retained spec rows reconcile exactly to the saved baseline-analysis-prep output columns.
- [ ] Review tables `73` through `79` were regenerated from baseline-analysis-prep outputs on disk only.
- [ ] This note remains a baseline-analysis-prep v1 review only and does not freeze the final endpoint or enable treatment modeling.

## Current Interpretation

This note remains a baseline-analysis-prep v1 review artifact only. It should answer whether the currently audited TCGA-only evidence is clean enough for descriptive statistics, missingness review, and baseline modeling preparation while keeping endpoint and treatment limitations explicit. It must not present this table as a final modeling dataset, a frozen endpoint dataset, a treatment-ready dataset, or a stronger clinical-effect analysis layer.
